Compare $FTH vs $IRWD | Chartloom

Compare

$FTH vs $IRWD

Faeth Therapeutics, Inc · Ironwood Pharmaceuticals Inc

FTH

Faeth Therapeutics, Inc

IRWD

Ironwood Pharmaceuticals Inc

Compare $FTH vs $IRWD

Comparing Faeth Therapeutics, Inc and Ironwood Pharmaceuticals Inc

FTHFaeth Therapeutics, Inc

IRWDIronwood Pharmaceuticals Inc

FTHFaeth Therapeutics, Inc

Market cap

$671M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

79.1%

52W performance

79.1%

FCF yield

-5.0%

IRWDIronwood Pharmaceuticals Inc

Market cap

$629M

P/E (TTM)

4.92x

Forward P/E (NTM)

2.96x

Forward P/S (NTM)

1.30x

Rev growth (TTM)

26.2%

YTD performance

-10.5%

52W performance

141.8%

FCF yield

29.5%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

FTH

IRWD

Detailed metrics comparison

FTH

Faeth Therapeutics, Inc

IRWD

Ironwood Pharmaceuticals Inc

Market Cap

FTH$671M

IRWD$629M

Enterprise Value

FTH$644M

IRWD$935M

Price

FTH$26.03

IRWD$3.82

P/E Ratio

FTHN/A

IRWD4.92x

P/S Ratio

FTH0.00x

IRWD1.62x

EV/Sales

FTH0.00x

IRWD2.40x

EV/EBITDA

FTH0.00x

IRWD3.93x

P/B Ratio

FTH4.08x

IRWD0.85x

P/FCF Ratio

FTHN/A

IRWD3.39x

EV/FCF

FTH-19.02x

IRWD5.04x

PEG Ratio

FTHN/A

IRWDN/A

Forward P/E (NTM)

FTHN/A

IRWD2.96x

Forward P/S (NTM)

FTHN/A

IRWD1.30x

Revenue (TTM)

FTH$0

IRWD$389M

Revenue Growth (YoY)

FTHN/A

IRWD26.2%

Forward Rev Growth

FTH77.6%

IRWD6.4%

Gross Margin (TTM)

FTH0.0%

IRWD100.0%

Operating Margin (TTM)

FTH0.0%

IRWD60.2%

EBITDA Margin (TTM)

FTH0.0%

IRWD61.1%

Net Margin (TTM)

FTH0.0%

IRWD33.4%

FCF Margin (TTM)

FTHN/A

IRWD47.7%

Net Income (TTM)

FTH$-196M

IRWD$130M

FCF (TTM)

FTH$-34M

IRWD$186M

EPS (TTM)

FTH-$34.65

IRWD$0.78

ROE (TTM)

FTH-18959.0%

IRWD29.3%

ROA (TTM)

FTH-17568.0%

IRWD34.3%

ROIC (TTM)

FTH-18946.0%

IRWD17.9%

Cash

FTH$27M

IRWD$79M

Debt

FTH$0

IRWD$385M

Net Cash/Debt

FTH$27M

IRWD$-306M

Current Ratio (TTM)

FTH19.69x

IRWD6.06x

Quick Ratio (TTM)

FTH19.55x

IRWD5.84x

Debt/Equity (TTM)

FTH0.00x

IRWD0.56x

Debt/Assets (TTM)

FTH0.0%

IRWD0.0%

Interest Coverage (TTM)

FTHN/A

IRWDN/A

Net Debt/EBITDA (TTM)

FTH0.00x

IRWD0.00x

Beta

FTH2.05

IRWD0.22

52W Performance

FTH79.1%

IRWD141.8%

YTD Performance

FTH79.1%

IRWD-10.5%

% from 52W High

FTH-38.2%

IRWD-33.9%

% from 52W Low

FTH93.8%

IRWD170.9%

Asset Turnover (TTM)

FTH0.00x

IRWD1.03x

FCF Yield (TTM)

FTH-5.0%

IRWD29.5%

Earnings Yield (TTM)

FTH-29.1%

IRWD20.7%

Dividend Yield (TTM)

FTHN/A

IRWDN/A

Rule of 40

FTH0.0

IRWD73.8

EV/GP/RG

FTHN/A

IRWD0.10

Ticker research

View FTH research View IRWD research

Metric	FTH Faeth Therapeutics, Inc	IRWD Ironwood Pharmaceuticals Inc
Market & Valuation
Market Cap	$671M	$629M
Enterprise Value	$644M	$935M
Price	$26.03	$3.82
P/E Ratio	N/A	4.92x
P/S Ratio	0.00x	1.62x
EV/Sales	0.00x	2.40x
EV/EBITDA	0.00x	3.93x
P/B Ratio	4.08x	0.85x
P/FCF Ratio	N/A	3.39x
EV/FCF	-19.02x	5.04x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	2.96x
Forward P/S (NTM)	N/A	1.30x
Revenue & Growth
Revenue (TTM)	$0	$389M
Revenue Growth (YoY)	N/A	26.2%
Forward Rev Growth	77.6%	6.4%
Profitability
Gross Margin (TTM)	0.0%	100.0%
Operating Margin (TTM)	0.0%	60.2%
EBITDA Margin (TTM)	0.0%	61.1%
Net Margin (TTM)	0.0%	33.4%
FCF Margin (TTM)	N/A	47.7%
Net Income (TTM)	$-196M	$130M
FCF (TTM)	$-34M	$186M
EPS (TTM)	-$34.65	$0.78
ROE (TTM)	-18959.0%	29.3%
ROA (TTM)	-17568.0%	34.3%
ROIC (TTM)	-18946.0%	17.9%
Financial Health
Cash	$27M	$79M
Debt	$0	$385M
Net Cash/Debt	$27M	$-306M
Current Ratio (TTM)	19.69x	6.06x
Quick Ratio (TTM)	19.55x	5.84x
Debt/Equity (TTM)	0.00x	0.56x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	2.05	0.22
52W Performance	79.1%	141.8%
YTD Performance	79.1%	-10.5%
% from 52W High	-38.2%	-33.9%
% from 52W Low	93.8%	170.9%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	1.03x
FCF Yield (TTM)	-5.0%	29.5%
Earnings Yield (TTM)	-29.1%	20.7%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	73.8
EV/GP/RG	N/A	0.10
Ticker research	View FTH research	View IRWD research

Valuation

P/E Ratio

IRWD

4.92x

P/S Ratio

FTH

0.00x

IRWD

1.62x

EV/FCF

FTH

-19.02x

IRWD

5.04x

Growth & revenue

Revenue Growth TTM

IRWD

26.2%

Forward Revenue Growth

FTH

77.6%

IRWD

6.4%

Profitability & performance

Gross Margin

IRWD

100.0%

FTH

0.0%

ROE

IRWD

29.3%

FTH

-18959.0%

FCF Yield %

IRWD

29.5%

FTH

-5.0%

52-Week Performance

IRWD

141.8%

FTH

79.1%

Detailed metrics comparison

FTH

Faeth Therapeutics, Inc

IRWD

Ironwood Pharmaceuticals Inc

Market Cap

FTH$671M

IRWD$629M

Enterprise Value

FTH$644M

IRWD$935M

Price

FTH$26.03

IRWD$3.82

P/E Ratio

FTHN/A

IRWD4.92x

P/S Ratio

FTH0.00x

IRWD1.62x

EV/Sales

FTH0.00x

IRWD2.40x

EV/EBITDA

FTH0.00x

IRWD3.93x

P/B Ratio

FTH4.08x

IRWD0.85x

P/FCF Ratio

FTHN/A

IRWD3.39x

EV/FCF

FTH-19.02x

IRWD5.04x

PEG Ratio

FTHN/A

IRWDN/A

Forward P/E (NTM)

FTHN/A

IRWD2.96x

Forward P/S (NTM)

FTHN/A

IRWD1.30x

Revenue (TTM)

FTH$0

IRWD$389M

Revenue Growth (YoY)

FTHN/A

IRWD26.2%

Forward Rev Growth

FTH77.6%

IRWD6.4%

Gross Margin (TTM)

FTH0.0%

IRWD100.0%

Operating Margin (TTM)

FTH0.0%

IRWD60.2%

EBITDA Margin (TTM)

FTH0.0%

IRWD61.1%

Net Margin (TTM)

FTH0.0%

IRWD33.4%

FCF Margin (TTM)

FTHN/A

IRWD47.7%

Net Income (TTM)

FTH$-196M

IRWD$130M

FCF (TTM)

FTH$-34M

IRWD$186M

EPS (TTM)

FTH-$34.65

IRWD$0.78

ROE (TTM)

FTH-18959.0%

IRWD29.3%

ROA (TTM)

FTH-17568.0%

IRWD34.3%

ROIC (TTM)

FTH-18946.0%

IRWD17.9%

Cash

FTH$27M

IRWD$79M

Debt

FTH$0

IRWD$385M

Net Cash/Debt

FTH$27M

IRWD$-306M

Current Ratio (TTM)

FTH19.69x

IRWD6.06x

Quick Ratio (TTM)

FTH19.55x

IRWD5.84x

Debt/Equity (TTM)

FTH0.00x

IRWD0.56x

Debt/Assets (TTM)

FTH0.0%

IRWD0.0%

Interest Coverage (TTM)

FTHN/A

IRWDN/A

Net Debt/EBITDA (TTM)

FTH0.00x

IRWD0.00x

Beta

FTH2.05

IRWD0.22

52W Performance

FTH79.1%

IRWD141.8%

YTD Performance

FTH79.1%

IRWD-10.5%

% from 52W High

FTH-38.2%

IRWD-33.9%

% from 52W Low

FTH93.8%

IRWD170.9%

Asset Turnover (TTM)

FTH0.00x

IRWD1.03x

FCF Yield (TTM)

FTH-5.0%

IRWD29.5%

Earnings Yield (TTM)

FTH-29.1%

IRWD20.7%

Dividend Yield (TTM)

FTHN/A

IRWDN/A

Rule of 40

FTH0.0

IRWD73.8

EV/GP/RG

FTHN/A

IRWD0.10

Ticker research

View FTH research View IRWD research

Metric	FTH Faeth Therapeutics, Inc	IRWD Ironwood Pharmaceuticals Inc
Market & Valuation
Market Cap	$671M	$629M
Enterprise Value	$644M	$935M
Price	$26.03	$3.82
P/E Ratio	N/A	4.92x
P/S Ratio	0.00x	1.62x
EV/Sales	0.00x	2.40x
EV/EBITDA	0.00x	3.93x
P/B Ratio	4.08x	0.85x
P/FCF Ratio	N/A	3.39x
EV/FCF	-19.02x	5.04x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	2.96x
Forward P/S (NTM)	N/A	1.30x
Revenue & Growth
Revenue (TTM)	$0	$389M
Revenue Growth (YoY)	N/A	26.2%
Forward Rev Growth	77.6%	6.4%
Profitability
Gross Margin (TTM)	0.0%	100.0%
Operating Margin (TTM)	0.0%	60.2%
EBITDA Margin (TTM)	0.0%	61.1%
Net Margin (TTM)	0.0%	33.4%
FCF Margin (TTM)	N/A	47.7%
Net Income (TTM)	$-196M	$130M
FCF (TTM)	$-34M	$186M
EPS (TTM)	-$34.65	$0.78
ROE (TTM)	-18959.0%	29.3%
ROA (TTM)	-17568.0%	34.3%
ROIC (TTM)	-18946.0%	17.9%
Financial Health
Cash	$27M	$79M
Debt	$0	$385M
Net Cash/Debt	$27M	$-306M
Current Ratio (TTM)	19.69x	6.06x
Quick Ratio (TTM)	19.55x	5.84x
Debt/Equity (TTM)	0.00x	0.56x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	2.05	0.22
52W Performance	79.1%	141.8%
YTD Performance	79.1%	-10.5%
% from 52W High	-38.2%	-33.9%
% from 52W Low	93.8%	170.9%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	1.03x
FCF Yield (TTM)	-5.0%	29.5%
Earnings Yield (TTM)	-29.1%	20.7%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	73.8
EV/GP/RG	N/A	0.10
Ticker research	View FTH research	View IRWD research